Singapore: Dr. Reddy's Laboratories has launched drug for psychiatric conditions, Divalproex Sodium extended release tab...
Singapore: FDA has granted tentative approval to India-based Strides Arcolab's HIV drug emtricitabine and tenofovir diso...
Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has launched authorized generic ...
Bangalore: Pioneers in genomics and bioinformatics in India, Genotypic Technology in association with the National Inst...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: After acquiring the formulations business of India's Piramal Healthcare in 2010, US drug major Abbott Laborat...
The diagnostics market in India is witnessing a 20 percent growth which is the faster than any country in the world (the...
The Indian local therapeutics market comprising of all biologics and vaccines for March 2012 has been estimated to be wo...
On May 13, 2013, Indian drug major Ranbaxy pleaded guilty to charges related to drug safety. The company admitted to hav...
New Delhi: The Indian Intellectual Property Appellate Board (IPAB) revoked two composition patents of US-based Allergan ...
Singapore: Sanofi Pasteur, the vaccines division of Sanofi, announced its further commitment to the international commun...
Singapore: US-based Multisorb Technologies will introduce its Calculations through Operations Program, StripPax System, ...
Singapore: India's Andhra Pradesh based Hyacinths Pharma that manufactures active pharmaceutical ingredients (APIs) is b...
Singapore: Mylan announced that its India-based subsidiary Mylan Laboratories has been selected as a leading supplier o...
New Delhi: The Indian seeds industry needs the right push as poor monsoons this year have once again highlighted the nee...
Singapore: Japanese companies are keen to collaborate with pharmaceutical companies in India. A delegation of pharmaceut...
Singapore: At the World Health Organization's regional committee meeting for the South East Asian region, India along wi...
Started with an initial investment of Rs4.5 crore two years ago, Regenerative Medical Services (RMS Regrow Regrow) is a ...
